Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Prolia
Pharma
Amid buzz for Amgen's obesity drug, company sees revenue boost
The buzz about Amgen’s obesity pipeline overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase.
Kevin Dunleavy
May 3, 2024 9:05am
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Mar 6, 2024 9:52am
Amgen's Prolia flagged by the FDA for risk of hypocalcemia
Jan 19, 2024 3:35pm
Amgen takes Novartis' Sandoz to court over bone med biosimilar
May 5, 2023 9:35am
Which drug price increases led to the most US spending?
Dec 7, 2022 9:20am
Bushu and Amgen expand Asian contract manufacturing pact
Nov 24, 2021 11:15am
